Biomarker-guided Management Post-Acute Coronary Syndromes: the BioMACS Study

The biomacs study biomarker-guided management following a heart attack

In Collaboration with Professor Robert Doughty


With supported from The University of Auckland and The Health Research Council of NZ


Duration: September 2019 to 2024


Biomarker-Guided Risk Management following Acute Coronary Syndromes: a Randomised, Controlled Trial (BioMACS).


Purpose:

The aim of this study is to determine whether a biomarker-guided approach to risk assessment and management will reduce clinical events for people following a heart attack.